FibroBiologics
在场
FibroBiologics 是一家在股票代码 FBLG (US) 下上市的公司。
涉及FibroBiologics的并购和融资。
- FibroBiologics 已提交其 IPO 档案。它的股票代码将是 FBLG。 (公布2024二月2号).
高管
查看带有其 9 名主要高管的组织结构图
FibroBiologics 搜索最多的简介
- Pete O'Heeron, Chief Executive Officer and Chairman of the Board
- Matt Link, Director
- Richard Cilento, Director
创建提醒
跟踪 FibroBiologics 的高管变动
生物技术
FibroBiologics 拥有 2,333 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Visus Therapeutics and Tenpoint Therapeutics have merged (公布2024十二月27号)..
- Deerfield has announced the acquisition of Singular Genomics (公布2024十二月24号).
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
FibroBiologics 的最新新闻稿
- Houston-based cell therapy company FibroBiologics to go public (updated)
- Press Releases
- Key Leadership Lessons for Biotech Executives from a Hospital Administrator - MedCity News
- Dr. Hamid Khoja: Using Fibroblasts to Treat Chronic Diseases | Docwire News
- Early Promise in Treating MS Seen With FibroBiologic's Fibroblast...
- The 2023 PharmaVoice Year in Preview
- Finding Therapies in Fibroblasts
- Dr. Hamid Khoja: Using Fibroblasts to Treat Chronic Diseases
- News - FibroBiologics
- View more press releases Close
通过电子邮件
